Abbott taps better sentiment to fund purchase of St Jude

New York

ABBOTT Laboratories took advantage of a post-election rally in healthcare debt to announce a US$15.1 billion bond on Thurs-day as it sought to fund its US$25 billion acquisition of rival St Jude Medical.

Changing sentiment towards healthcare companies following Donald Trump's surprise electoral victory was seen benefiting the medical device maker, which has been struggling to carry out its aggressive expansion plans.